MDS Pharma Services
Renzo DiCarlo is Vice President and General Manager of the Global Central Lab line of business of MDS Pharma Services.
Prior to joining MDS Pharma Services, he spent more than a decade with MDS Nordion, most recently as Managing Director of MDS Nordion SA, based in Belgium. In this role, he was responsible for the profitability turn around of this Nuclear Medicine products business. His previous positions in the Nuclear Medicine business of MDS Nordion include Vice President of Operations, and Director of Radiopharmaceutical Operations and R&D.
Mr. DiCarlo earned a Bachelor of Science degree in Mechanical Engineering at the University of Toronto and an MBA at Queenâ€s University. He is fluently trilingual in English, French and Italian.
This person is not in any offices
MDS Pharma Services
A global contract research organization (CRO) that offers a full spectrum of resources to meet the drug discovery and drug development needs of the pharmaceutical and biotechnology industries. With facilities in more than 23 countries, MDS Pharma Services applies advanced scientific and technological expertise to each stage of the drug discovery and development process: discovery, preclinical, early clinical research (phases I-IIa), bioanalytical, global clinical research (phases IIb-IV), and central lab.